Comedian and social media influencer Aishwarya Mohanraj has recently spoken candidly about her journey with weight loss, highlighting her experience with Mounjaro, a GLP-1 medication. In a detailed YouTube video lasting about 15 minutes, she chronicled her efforts, which commenced last year and included a focus on a healthy diet and regular exercise. However, her progress was interrupted by a diagnosis of Plantar Fasciitis, which forced her to halt her workout regimen. With the desire to achieve a more defined jawline, she ultimately turned to Mounjaro.
Since the introduction of GLP-1 drugs in India, they have gained popularity as effective weight loss solutions, with Mounjaro emerging as the top choice in the market. In October 2025 alone, the drug reached sales figures of Rs 100 crore. The market has recently welcomed other GLP-1 injections, including Wegovy and Ozempic, both produced by Novo Nordisk. Originally intended to treat type 2 diabetes, these medications work by imitating gut hormones that manage appetite and blood sugar levels, thereby aiding in weight loss.
Mohanraj’s Experience with Mounjaro
Aishwarya Mohanraj shared that for six months, she administered weekly Mounjaro injections, each costing Rs 4,000. She later adjusted her dosage to twice a month, followed by once a month, and she intends to discontinue its use soon. While acknowledging the financial implications, she stressed the significance of professional medical advice before starting such treatments.
Initially motivated by the desire to eliminate her double chin, Aishwarya employed strategies including hiring a trainer and nutritionist, exercising regularly, and increasing protein consumption while reducing junk food intake. Despite her diligence, health conditions such as PCOS and hyperthyroidism posed additional hurdles in her weight loss efforts. A major setback occurred when she was diagnosed with Plantar Fasciitis a condition characterised by heel pain due to microtears in the ligament, often associated with overuse and obesity.
Public Reaction to Her Honesty
Since the release of her video, Aishwarya received an outpouring of support for her transparency about her weight loss journey. Comments from viewers on various platforms praised her for breaking the silence often surrounding the use of weight loss medications. One user remarked on Instagram, commending her bravery for sharing her story, while another noted how refreshing her honesty was compared to other influencers who may present misleading narratives.
Despite the encouragement, some viewers criticised her for not adhering to traditional weight loss methods. Nevertheless, many have expressed admiration for her commitment to truthfulness, particularly given the unrealistic standards often showcased in the weight loss community. This conversation has sparked discussions about accepting diverse paths to achieving health and wellness, especially among those who face unique challenges.
Challenges and Side Effects of GLP-1 Drugs
Aishwarya’s openness also touched on the side effects associated with GLP-1 medications. She reported experiencing nausea and chronic hair loss as part of her treatment. It is important for individuals considering these drugs for weight loss to consult healthcare professionals to understand the potential risks, which can include severe gastrointestinal issues and nutrient imbalances.
Aishwarya Mohanraj’s account has offered a rare glimpse into the often obscured realities of weight loss and body image, sparking conversations about honesty and authenticity in health journeys. Her story may provide a sense of relief for individuals grappling with similar experiences, reminding them they are not alone in their struggles.
